CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization
Pawel E. Buszman, MD, FACC*, ,*,
Stefan R. Kiesz, MD, FACC ,,
Andrzej Bochenek, MD*,
Ewa Peszek-Przybyla, MD ,
Iwona Szkrobka, MD,
Marcin Debinski, MD,
Bozena Bialkowska, MD,
Dariusz Dudek, MD||,
Agata Gruszka, MD,
Aleksander Zurakowski, MD,
Krzysztof Milewski, MD,
Miroslaw Wilczynski, MD,
Lukasz Rzeszutko, MD||,
Piotr Buszman*,
Jan Szymszal, PhD¶,
Jack L. Martin, MD, FACC# and
Michal Tendera, MD, FACC*
* Medical University of Silesia, Katowice, Poland
San Antonio Endovascular and Heart Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas
American Heart of Poland, Ustron, Poland
Upper-Silesian Heart Centre, Katowice, Poland
|| Jagiellonian University, Krakow, Poland
¶ Silesian School of Engineering, Katowice, Poland
# Bryn Mawr and Thomas Jefferson University, Philadelphia, Pennsylvania.
Manuscript received March 21, 2007;
revised manuscript received September 10, 2007,
accepted September 17, 2007.
* Reprint requests and correspondence: Dr. Pawel E. Buszman, Katowice 40-635, Ziolowa 45/47, Poland. (Email: pbuszman{at}ka.onet.pl).
Objectives: The purpose of this study was to compare the early and late results of percutaneous and surgical revascularization of left main coronary artery stenosis.
Background: Unprotected left main coronary artery (ULMCA) stenting is being investigated as an alternative to bypass surgery.
Methods: We randomly assigned 105 patients with ULMCA stenosis to percutaneous coronary intervention (PCI; 52 patients) or coronary artery bypass grafting (CABG; 53 patients). The primary end point was the change in left ventricular ejection fraction (LVEF) 12 months after the intervention. Secondary end points included 30-day major adverse events (MAE), major adverse cardiac and cerebrovascular events (MACCE), length of hospitalization, target vessel failure (TVF), angina severity and exercise tolerance after 1 year, and total and MACCE-free survival.
Results: A significant increase in LVEF at the 12-month follow-up was noted only in the PCI group (3.3 ± 6.7% after PCI vs. 0.5 ± 0.8% after CABG; p = 0.047). Patients performed equally well on stress tests, and angina status improved similarly in the 2 groups. PCI was associated with a lower 30-day risk of MAE (p < 0.006) and MACCE (p = 0.03) and shorter hospitalizations (p = 0.0007). Total and MACCE-free 1-year survival was comparable. Left main TVF was similar in the 2 groups. During the 28.0 ± 9.9-month follow-up, there were 3 deaths in the PCI group and 7 deaths in the CABG group (p = 0.08).
Conclusions: Patients with ULMCA disease treated with PCI had favorable early outcomes in comparison with the CABG group. At 1 year, LVEF had improved significantly only in the PCI group. After more than 2 years, MACCE-free survival was similar in both groups with a trend toward improved survival after PCI. (Study of Unprotected Left Main Stenting Versus Bypass Surgery [LE MANS study]; NCT00375063).
|
Abbreviations and Acronyms
| | BMS = bare-metal stent(s) | | CABG = coronary artery bypass grafting | | DES = drug-eluting stent(s) | | LVEF = left ventricular ejection fraction | | MACCE = major adverse cardiac and cerebrovascular events | | MAE = major adverse events | | PCI = percutaneous coronary intervention | | TVF = target vessel failure | | TVR = target vessel revascularization | | ULMCA = unprotected left main coronary artery |
|
This article has been cited by other articles:
|
|
|
|
 
D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol.,
June 23, 2009;
53(25):
2389 - 2403.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol.,
June 2, 2009;
53(22):
2080 - 2097.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Soran, A. Manchanda, and S. Schueler
Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective
Interactive CardioVascular and Thoracic Surgery,
June 1, 2009;
8(6):
666 - 671.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-J. Park, Y.-H. Kim, D.-W. Park, S.-W. Lee, W.-J. Kim, J. Suh, S.-C. Yun, C. W. Lee, M.-K. Hong, J.-H. Lee, et al.
Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis
Circ Cardiovasc Intervent,
June 1, 2009;
2(3):
167 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Alfonso
Left main coronary artery stenting crossing the rubicon.
J. Am. Coll. Cardiol.,
May 12, 2009;
53(19):
1769 - 1772.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Mehilli, A. Kastrati, R. A. Byrne, O. Bruskina, R. Iijima, S. Schulz, J. Pache, M. Seyfarth, S. Massberg, K.-L. Laugwitz, et al.
Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease
J. Am. Coll. Cardiol.,
May 12, 2009;
53(19):
1760 - 1768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Vaquerizo, T. Lefevre, O. Darremont, M. Silvestri, Y. Louvard, J. L. Leymarie, P. Garot, H. Routledge, F. de Marco, T. Unterseeh, et al.
Unprotected Left Main Stenting in the Real World: Two-Year Outcomes of the French Left Main Taxus Registry
Circulation,
May 5, 2009;
119(17):
2349 - 2356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Takagi, H. Manabe, N. Kawai, S.-n. Goto, and T. Umemoto
Unprotected left main coronary artery stenting versus coronary artery bypass graft surgery.
Ann. Thorac. Surg.,
May 1, 2009;
87(5):
1651 - 1652.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Serruys, M.-C. Morice, A. P. Kappetein, A. Colombo, D. R. Holmes, M. J. Mack, E. Stahle, T. E. Feldman, M. van den Brand, E. J. Bass, et al.
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
N. Engl. J. Med.,
March 5, 2009;
360(10):
961 - 972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Lange and L. D. Hillis
Coronary Revascularization in Context
N. Engl. J. Med.,
March 5, 2009;
360(10):
1024 - 1026.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Smith
Surgery, Not Percutaneous Revascularization, Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
Circulation,
February 24, 2009;
119(7):
1013 - 1020.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Teirstein
Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
Circulation,
February 24, 2009;
119(7):
1021 - 1033.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-J. Park and D.-W. Park
Percutaneous Coronary Intervention With Stent Implantation Versus Coronary Artery Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Is It Time to Change Guidelines?
Circ Cardiovasc Intervent,
February 1, 2009;
2(1):
59 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008.
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Takagi, N. Kawai, and T. Umemoto
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of comparative studies.
J. Thorac. Cardiovasc. Surg.,
January 1, 2009;
137(1):
e54 - e57.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Price, D. E. Kandzari, and P. S. Teirstein
Change We Can Believe In: The Hyper-Evolution of Percutaneous Coronary Intervention for Unprotected Left Main Disease With Drug-Eluting Stents
Circ Cardiovasc Intervent,
December 1, 2008;
1(3):
164 - 166.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wu, E. L. Hannan, G. Walford, and D. P. Faxon
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery
Ann. Thorac. Surg.,
October 1, 2008;
86(4):
1153 - 1159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Meliga, M. Valgimigli, P. Buszman, and P. W. Serruys
Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Disease: The Endless Debate
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
582 - 584.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Randomized Study of Left-Main Stenting
Journal Watch Cardiology,
March 5, 2008;
2008(305):
2 - 2.
[Full Text]
|
|
|
|
|
|
|
D. P. Taggart, S. Kaul, W. E. Boden, T. B. Ferguson Jr, R. A. Guyton, M. J. Mack, P. T. Sergeant, R. J. Shemin, P. K. Smith, and S. Yusuf
Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery.
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
885 - 892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
